+48.6%
ENTG vs BBIO
+154.4%
-105.8%
-56.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.2% | -0.1% | +2.2% | +2.2% |
| 7D | +1.2% | -3.2% | +4.4% | +2.1% |
| 30D | -12.9% | -13.6% | +0.7% | -9.3% |
| 3M | -3.1% | +7.2% | -10.3% | -5.2% |
| 6M | +21.0% | +1.5% | +19.5% | +20.0% |
| YTD | +67.0% | -5.3% | +72.3% | +66.9% |
| 1Y | +68.6% | +37.7% | +30.9% | +51.2% |
| 3Y | +48.6% | +153.9% | -105.3% | +5.3% |
| All | +48.6% | +154.4% | -105.8% | +5.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling